Entera Bio Ltd.
ENTX
$2.89
$0.020.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 42.00K | 124.00K | 166.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 42.00K | 124.00K | 166.00K |
| Cost of Revenue | 0.00 | 0.00 | 42.00K | 124.00K | 166.00K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expenses | 5.59M | 5.37M | 5.53M | 5.34M | 5.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.40M | 12.51M | 11.57M | 10.95M | 10.76M |
| Operating Income | -14.40M | -12.51M | -11.53M | -10.82M | -10.59M |
| Income Before Tax | -17.03M | -12.38M | -11.44M | -10.77M | -10.59M |
| Income Tax Expenses | -- | -- | -- | 14.00K | 14.00K |
| Earnings from Continuing Operations | -17.03 | -12.38 | -11.44 | -10.78 | -10.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.03M | -12.38M | -11.44M | -10.78M | -10.60M |
| EBIT | -14.40M | -12.51M | -11.53M | -10.82M | -10.59M |
| EBITDA | -14.37M | -12.48M | -11.50M | -10.79M | -10.55M |
| EPS Basic | -0.35 | -0.26 | -0.25 | -0.24 | -0.26 |
| Normalized Basic EPS | -0.22 | -0.16 | -0.15 | -0.15 | -0.16 |
| EPS Diluted | -0.35 | -0.26 | -0.25 | -0.24 | -0.26 |
| Normalized Diluted EPS | -0.22 | -0.16 | -0.15 | -0.15 | -0.16 |
| Average Basic Shares Outstanding | 192.57M | 188.96M | 184.58M | 176.41M | 166.97M |
| Average Diluted Shares Outstanding | 192.57M | 188.96M | 184.58M | 176.41M | 166.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |